← Leaderboards
Vivianne L Tawfik
Stanford University
$6,356,077
Attributed
$6,356,077
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,356,077 · 5
By mechanism
R35$2,582,966 · 1
RF1$2,249,392 · 1
K08$697,294 · 1
R21$437,254 · 1
T32$389,171 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Heike Elizabeth Daldrup-Link$23,256,656
- Gary K Steinberg$22,141,624
- Marion S Buckwalter$7,380,483
- Paul George$2,197,815
- James F Fries$7,095,417
Others in their field
Other Emerging Leaders on “Pain”
- Abraham Aizer Brody · New York University School Of Medicine$25,530,786
- Jeffrey Reich · Sparian Biosciences, Inc.$21,671,295
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Barbara Burtness · Yale University$11,235,253
- William Russell Renthal · Brigham And Women'S Hospital$11,023,625
Research focus
PainInjuryPeripheralPersistent PainCellsMolecularChronic PainCytokineAffectTraumaSpinal CordYolk SacResponse To InjuryMicrogliaCell LineageInnate Immune ResponseTissuesMouse ModelMonitorLigandsCellular TargetingPositron-Emission TomographyAmericanAffective
Grant awards (18)
Myeloid lineage targeting to improve recovery from injury and surgery: Cellular and molecular mechanism$433,743
R35 · FY2025 · GM · contact PI
Research in Anesthesia Training Program (ReAP)$389,171
T32 · FY2025 · GM · contact PI
Validation of neuronal senescence as a target for chronic pain in aging$2,249,392
RF1 · FY2024 · AG · contact PI
Myeloid lineage targeting to improve recovery from injury and surgery: Cellular and molecular mechanisms$401,240
R35 · FY2024 · GM · contact PI
Myeloid lineage targeting to improve recovery from injury and surgery: Cellular and molecular mechanisms$77,915
R35 · FY2024 · GM · contact PI
Myeloid lineage targeting to improve recovery from injury and surgery: Cellular and molecular mechanisms$38,958
R35 · FY2024 · GM · contact PI
Myeloid lineage targeting to improve recovery from injury and surgery: Cellular and molecular mechanisms$401,240
R35 · FY2023 · GM · contact PI
Cellular senescence in chronic pain and aging$198,210
R21 · FY2023 · AG · contact PI
Myeloid lineage targeting to improve recovery from injury and surgery: Cellular and molecular mechanisms$12,398
R35 · FY2023 · GM · contact PI
Myeloid lineage targeting to improve recovery from injury and surgery: Cellular and molecular mechanisms$401,473
R35 · FY2022 · GM · contact PI
Cellular senescence in chronic pain and aging$239,044
R21 · FY2022 · AG · contact PI
Myeloid lineage targeting to improve recovery from injury and surgery: Cellular and molecular mechanisms$401,939
R35 · FY2021 · GM · contact PI
Myeloid lineage targeting to improve recovery from injury and surgery: Cellular and molecular mechanisms$12,722
R35 · FY2021 · GM · contact PI
Myeloid lineage targeting to improve recovery from injury and surgery: Cellular and molecular mechanisms$401,338
R35 · FY2020 · GM · contact PI
Peripheral and central immune contributions to pain chronification$109,070
K08 · FY2020 · NS · contact PI
Peripheral and central immune contributions to pain chronification$196,048
K08 · FY2019 · NS · contact PI
Peripheral and central immune contributions to pain chronification$196,048
K08 · FY2018 · NS · contact PI
Peripheral and central immune contributions to pain chronification$196,128
K08 · FY2017 · NS · contact PI